New Drug R amp;amp; D and Intellectual Property.doc

 PAGE \* MERGEFORMAT 17 New Drug R amp;amp; D and Intellectual Property [Keywords:] new drug R amp;amp; D IP Well-known American economist, Mansfield and the German research and analysis concluded that the absence of patent protection, 60% of the new drug would not have been invented, which fully explains the development of patent protection for pharmaceutical significance [1]. In the four kinds of intellectual property protection of new drugs, only the patent protection in the form of the state of law established to protect, and because the strength of patent protection, the strongest, most extensive, with exclusive, the protection of the longest time, as well as the lowest cost, so the patent protection is the most comprehensive, highest level of protection, the other is essentially three kinds of protection by the State Drug Administration and the State Administration of Chinese medicine given to the administrative protection measures, therefore, three kinds of protection have to be subject to patent protection, that is, When the drug protection, medicine and drug administrative protection of variety protection and patent protection to patent protection when the conflict shall prevail. Patent protection for both the protection products, but also to protect the product preparation process and new uses, and the extension of its protection the most, with a new structure for the chemical compounds in the patents obtained after the preparation with the compound-related aspects of containing the substance agents and their uses have been protected at the same time, its scope of protection includes not only the production and use of patented products, but also includes the sale of patented products, offering for sale and import, methods, scope of protection of patent rights include not only the direct use of the method, but also includes directly obtained by the patented product. While the other type of protection only to protect the production of the product it